Controlled Drugs and Substances Act Canadian federal drug regulation act
The Controlled Drugs and Substances Act (French : Loi réglementant certaines drogues et autres substances ) is Canada 's federal drug control statute. Passed in 1996 under Prime Minister Jean Chrétien 's government, it repeals the Narcotic Control Act and Parts III and IV of the Food and Drugs Act , and establishes eight Schedules of controlled substances and two Classes of precursors . It provides that "The Governor in Council may, by order, amend any of Schedules I to VIII by adding to them or deleting from them any item or portion of an item, where the Governor in Council deems the amendment to be necessary in the public interest."
The Act serves as the implementing legislation for the Single Convention on Narcotic Drugs , the Convention on Psychotropic Substances , and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances .
Amendments to the act
In November 2007, the Justice Minister Rob Nicholson introduced Bill C-26, which proposed a number of mandatory minimum penalties imposed on those who commit drug offences.
On 27 February 2009, Bill C-15, a re-introduction of C-26 received first reading in the second session of the 40th Parliament of Canada.[ 1] On 9 June 2009, the House of Commons passed Bill C-15 and it went to the Senate for study and approval. On 14 December 2009, the Senate passed Bill C-15, with some amendments, for approval by the House of Commons. When the Canadian Parliament dissolved in a prorogation on 31 January 2010, Bill C-15, along with all unpassed legislation then tabled before the Commons, fell.
Early in 2012, the next parliament passed the Safe Streets and Communities Act , which received Royal Assent in March. The final legislation sees changes made to four areas of the Act , outlining mandatory minimum sentences for offences relating to the trafficking and production of various controlled substances. Mandatory minimum sentencing does not apply to simple possession and trafficking in smaller amounts.[citation needed ]
On 17 October 2018, the federal Cannabis Act came into effect, legalizing the possession, sale and production of cannabis. Everyone with a criminal record for cannabis possession became eligible to apply for a pardon on this date.[citation needed ]
List of drugs
The list below reflects the list of drugs scheduled in Canada's Controlled Drugs and Substances Act .[ 2]
Schedule I
Opium Poppy (Papaver somniferum ), its preparations, derivatives, alkaloids and salts, including:
Opium
Codeine (methylmorphine)
Morphine (7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol)
Thebaine (paramorphine)
and the salts, derivatives and salts of derivatives of the substances set out in subitems (1) to (4), including:
Acetorphine (acetyletorphine)
Acetyldihydrocodeine (4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol acetate)
Benzylmorphine (7,8-didehydro-4,5-epoxy-17-methyl-3-(phenylmethoxy) morphinan-6-ol)
Codoxime (dihydrocodeinone O-(carboxymethyl) oxime)
Desomorphine (dihydrodeoxymorphine)
Diacetylmorphine (heroin )
Dihydrocodeine (4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol)
Dihydromorphine (4,5-epoxy-17-methylmorphinan-3,6-diol)
Ethylmorphine (7,8-didehydro-4,5-epoxy-3-ethoxy-17-methylmorphinan-6-ol)
Etorphine (tetrahydro-7α-(1-hydroxy-1-methyl-butyl)-6,14-endo-ethenooripavine)
Hydrocodone (dihydrocodeinone)
Hydromorphinol (dihydro-14-hydroxymorphine)
Hydromorphone (dihydromorphinone)
Methyldesorphine (Δ6-deoxy-6-methylmorphine)
Methyldihydromorphine (dihydro-6-methylmorphine)
Metopon (dihydromethylmorphinone)
Morphine-N-oxide (morphine oxide)
Myrophine (benzylmorphine myristate)
Nalorphine (N-allylnormorphine)
Nicocodine (6-nicotinylcodeine)
Nicomorphine (dinicotinylmorphine)
Norcodeine (N-desmethylcodeine)
Normorphine (N-desmethylmorphine)
Oxycodone (dihydrohydroxycodeinone)
Oxymorphone (dihydrohydroxymorphinone)
Pholcodine (3-[2-(4-morpholinyl)ethyl]morphine)
Thebacon (acetyldihydrocodeinone)
but not including:
Apomorphine (5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol) and its salts
Cyprenorphine (N-(cyclopropylmethyl)-6,7,8,14-tetrahydro-7α-(1-hydroxy-1-methylethyl)-6,14-endo-ethenonororipavine) and its salts
Nalmefene (17-(cyclopropylmethyl)-4,5α-epoxy-6-methylenemorphinan-3,14-diol) and its salts
Naloxone (4,5α-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one) and its salts
Naltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one) and its salts
Methylnaltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium) and its salts
Naloxegol (4,5α-epoxy-6α-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propenyl)morphinan-3,14-diol) and its salts
Narcotine (6,7-dimethoxy-3-(5,6,7,8-tetra-hydro-4-methoxy-6-methyl-1,3-dioxolos [4,5-g]isoquinolin-5-yl)-1(3H)-isobenzofuranone) and its salts
Papaverine (1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline) and its salts
Poppy seed
Coca (Erythroxylon ), its preparations, derivatives, alkaloids and salts, including:
Coca leaves
Cocaine (benzoylmethylecgonine)
Ecgonine (3-hydroxy-2-tropane carboxylic acid)
but not including:
123 l-ioflupane
Phenylpiperidines , their intermediates, salts, derivatives and analogues and salts of intermediates, derivatives and analogues, including:
Allylprodine (3-allyl-1-methyl-4-phenyl-4-piperidinol propionate)
Alphameprodine (α-3-ethyl-1-methyl-4-phenyl-4-piperidinol propionate)
Alphaprodine (α-1,3-dimethyl-4-phenyl-4-piperidinol propionate)
Anileridine (ethyl 1-[2-(p-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate)
Betameprodine (β-3-ethyl-1-methyl-4-phenyl-4-piperidinol propionate)
Betaprodine (β-1,3-dimethyl-4-phenyl-4-piperidinol propionate)
Benzethidine (ethyl 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylate)
Diphenoxylate (ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylate)
Difenoxin (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylate)
Etoxeridine (ethyl 1-[2-(2-hydroxyethoxy) ethyl]-4-phenylpiperidine-4-carboxylate)
Furethidine (ethyl 1-(2-tetrahydrofurfury loxyethyl)-4-phenylpiperidine-4-carboxylate)
Hydroxypethidine (ethyl 4-(m-hydroxyphenyl)-1-methylpiperidine-4-carboxylate)
Ketobemidone (1-[4-(m-hydroxyphenyl)-1-methyl-4-piperidyl]-1-propanone)
Methylphenylisonipecotonitrile (4-cyano-1-methyl-4-phenylpiperidine)
Morpheridine (ethyl 1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylate)
Norpethidine (ethyl 4-phenylpiperidine-4-carboxylate)
Pethidine (ethyl 1-methyl-4-phenylpiperidine-4-carboxylate)
Phenoperidine (ethyl 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylate)
Piminodine (ethyl 1-[3-(phenylamino)propyl]-4-phenylpiperidine-4-carboxylate)
Properidine (isopropyl 1-methyl-4-phenylpiperidine-4-carboxylate)
Trimeperidine (1,2,5-trimethyl-4-phenyl-4-piperidinol propionate)
Pethidine Intermediate C (1-methyl-4-phenylpiperidine-4-carboxylate)
but not including:
Carbamethidine (ethyl 1-(2-carbamylethyl)-4-phenylpiperidine-4-carboxylate) and its salts
Oxpheneridine (ethyl 1-(2-hydroxy-2-phenylethyl)-4-phenylpiperidine-4-carboxylate) and its salts
Phenazepines, their salts, derivatives and salts of derivatives including:
Proheptazine (hexahydro-1,3-dimethyl-4-phenyl-1H-azepin-4-ol propionate)
but not including:
Ethoheptazine (ethyl hexahydro-1-methyl-4-phenyl-azepine-4-carboxylate) and its salts
Metethoheptazine (ethyl hexahydro-1,3-dimethyl-4-phenylazepine-4-carboxylate) and its salts
Metheptazine (methyl hexahydro-1,2-dimethyl-4-phenylazepine-4-carboxylate) and its salts
Amidones , their intermediates, salts, derivatives and salts of intermediates and derivatives including:
Dimethylaminodiphenylbutanonitrile (4-cyano-2-dimethylamino-4,4-diphenylbutane)
Dipipanone (4,4-diphenyl-6-piperidino-3-heptanone)
Isomethadone (6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone)
Methadone (6-dimethylamino-4,4-diphenyl-3-heptanone)
Normethadone (6-dimethylamino-4,4-diphenyl-3-hexanone)
Norpipanone (4,4-diphenyl-6-piperidino-3-hexanone)
Phenadoxone (6-morpholino-4,4-diphenyl-3-heptanone)
Methadols , their salts, derivatives and salts of derivatives including:
Acetylmethadol (6-dimethylamino-4,4-diphenyl-3-heptanol acetate)
Alphacetylmethadol (α-6-dimethylamino-4,4-diphenyl-3-heptanol acetate)
Alphamethadol (α-6-dimethylamino-4,4-diphenyl-3-heptanol)
Betacetylmethadol (β-6-dimethylamino-4,4-diphenyl-3-heptanol acetate)
Betamethadol (β-6-dimethylamino-4,4-diphenyl-3-heptanol)
Dimepheptanol (6-dimethylamino-4,4-diphenyl-3-heptanol)
Noracymethadol (α-6-methylamino-4,4-diphenyl-3-heptanol acetate)
Phenalkoxams, their salts, derivatives and salts of derivatives including:
Dimenoxadol (dimethylaminoethyl 1-ethoxy-1,1-diphenylacetate)
Dioxaphetyl butyrate (ethyl 2,2-diphenyl-4-morpholinobutyrate)
Dextropropoxyphene ([S-(R*,S*)]-α-[2-(dimethylamino)-1-methylethyl]-α-phenylbenzeneethanol, propanoate ester)
Thiambutenes , their salts, derivatives and salts of derivatives including:
Diethylthiambutene (N,N-diethyl-1-methyl-3,3-di-2-thienylallylamine)
Dimethylthiambutene (N,N,1-trimethyl-3,3-di-2-thienylallylamine)
Ethylmethylthiambutene (N-ethyl-N,1-dimethyl-3,3-di-2-thienylallylamine)
Moramides , their intermediates, salts, derivatives and salts of intermediates and derivatives including:
Dextromoramide (d-1-(3-methyl-4-morpholino-2,2-diphenylbutyryl)pyrrolidine)
Diphenylmorpholinoisovaleric acid (2-methyl-3-morpholino-1,1-diphenylpropionic acid)
Levomoramide (l-1-(3-methyl-4-morpholino-2,2-diphenylbutyryl)pyrrolidine)
Racemoramide (d,l-1-(3-methyl-4-morpholino-2,2-diphenylbutyryl) pyrrolidine)
Morphinans , their salts, derivatives and salts of derivatives including:
Buprenorphine (17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-α-methyl-6,14-ethenomorphinan-7-methanol)
Drotebanol (6β,14-dihydroxy-3,4-dimethoxy-17-methylmorphinan)
Levomethorphan (l-3-methoxy-17-methylmorphinan)
Levorphanol (l-3-hydroxy-17-methylmorphinan)
Levophenacylmorphan (l-3-hydroxy-17-phenacylmorphinan)
Norlevorphanol (l-3-hydroxymorphinan)
Phenomorphan (3-hydroxy-17-(2-phenylethyl)morphinan)
Racemethorphan (d,1-3-methoxy-17-methylmorphinan)
Racemorphan (d,l-3-hydroxy-N-methylmorphinan)
but not including:
Dextromethorphan (d-1,2,3,9,10,10a-hexahydro-6-methoxy-11-methyl-4H-10,4a-iminoethano-phenanthren) and its salts
Dextrorphan (d-1,2,3,9,10,10a-hexahydro-11-methyl-4H-10,4a-iminoethanophenanthren-6-ol) and its salts
Levallorphan (l-11-allyl-1,2,3,9,10,10a-hexahydro-4H-10,4a-iminoethanophenanthren-6-ol) and its salts
Levargorphan (l-11-propargyl-1,2,3,9,10,10a-hexahydro-4H-10,4a-iminoethanophenanthren-6-ol) and its salts
Butorphanol (17-(cyclobutylmethyl)morphinan-3,14-diol) and its salts
Nalbuphine (17-(cyclobutylmethyl)-4,5α-epoxymorphinan-3,6α, 14-triol) and its salts
Benzazocines , their salts, derivatives and salts of derivatives including:
Phenazocine (1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-phenethyl-2,6-methano-3-benzazocin-8-ol)
Metazocine (1,2,3,4,5,6-hexahydro-3,6,11-trimethyl-2,6-methano-3-benzazocin-8-ol)
Pentazocine (1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol)
but not including:
Cyclazocine (1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(cyclopropylmethyl)-2,6-methano-3-benzazocin-8-ol) and its salts
Ampromides , their salts, derivatives and salts of derivatives including:
Diampromide (N-[2-(methylphenethylamino)propyl] propionanilide)
Phenampromide (N-(1-methyl-2-piperidino) ethyl) propionanilide)
Propiram (N-(1-methyl-2-piperidinoethyl)-N-2-pyridylpropionamide)
Benzimidazoles , their salts, derivatives and salts of derivatives including:
Clonitazene (2-(p-chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole)
Etonitazene (2-(p-ethoxybenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole)
Bezitramide (1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)-piperidine)
Phencyclidine (1-(1-phenylcyclohexyl)piperidine), its salts, derivatives and analogues and salts of derivatives and analogues, including:
Ketamine (2-(2-chlorophenyl)-2-(methylamino)cyclohexanone)
Piritramide (1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4-carboxylic acid amide), its salts, derivatives and salts of derivatives
Fentanyls , their salts, derivatives, and analogues and salts of derivatives and analogues, including:
Acetyl-α-methylfentanyl (N-[1-(α-methylphenethyl)-4-piperidyl] acetanilide)
Alfentanil (N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidyl]propionanilide)
Carfentanil (methyl 4-[(1-oxopropyl)phenylamino]-1-(2-phenethyl)-4-piperidinecarboxylate)
p-Fluorofentanyl (4′fluoro-N-(1-phenethyl-4-piperidyl) propionanilide)
Fentanyl (N-(1-phenethyl-4-piperidyl) propionanilide)
β-Hydroxyfentanyl (N-[1-(β-hydroxyphenethyl)-4-piperidyl] propionanilide)
β-Hydroxy-3-methylfentanyl (N-[1-(β-hydroxyphenethyl)-3-methyl-4-piperidyl] propionanilide)
α-Methylfentanyl (N-[1-(α-methylphenethyl)-4-piperidyl] propionanilide)
α-Methylthiofentanyl (N-[1-[1-methyl-2-(2-thienyl) ethyl]-4-piperidyl] propionanilide)
3-Methylfentanyl (N-(3-methyl-1-phenethyl-4-piperidyl) propionanilide)
3-Methylthiofentanyl (N-[3-methyl-1-[2-(2-thienyl) ethyl]-4-piperidyl] propionanilide)
Remifentanil (dimethyl 4-carboxy-4-(N-phenylpropionamido)-1-piperidinepropionate)
Sufentanil (N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl] propionanilide)
Thiofentanyl (N-[1-[2-(2-thienyl)ethyl]-4-piperidyl] propionanilide)
Tilidine (ethyl2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate), its salts, derivatives and salts of derivatives
Methylenedioxypyrovalerone (MDPV ), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
Methamphetamine (N,α-dimethylbenzeneethanamine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
Amphetamines , their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:
Amphetamine (α-methylbenzene-ethanamine)
N-ethylamphetamine (N-ethyl-α-methylbenzeneethanamine)
4-methyl-2,5-dimethoxyamphetamine (STP) (2,5-dimethoxy-4,α-dimethylbenzeneethanamine)
3,4-Methylenedioxyamphetamine (MDA) (α-methyl-1,3-benzodioxole-5-ethanamine)
2,5-dimethoxyamphetamine (2,5-dimethoxy-α-methylbenzene-ethanamine)
4-methoxyamphetamine (4-methoxy-α-methylbenzeneethanamine)
2,4,5-trimethoxyamphetamine (2,4,5-trimethoxy-α-methylbenzeneethanamine)
N-methyl-3,4-methylenedioxy- amphetamine (N,α-dimethyl-1,3-benzodioxole-5-ethanamine)
4-ethoxy-2,5-dimethoxyamphetamine (4-ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)
5-methoxy-3,4-methylenedioxy- amphetamine (7-methoxy-α-methyl-1,3-benzodioxole-5-ethanamine)
N,N-dimethyl-3,4-methylenedioxyamphetamine (N,N, α-trimethyl-1,3-benzodioxole-5-ethanamine)
N-ethyl-3,4-methylenedioxyamphetamine (N-ethyl-α-methyl-1,3-benzodioxole-5-ethanamine)
4-ethyl-2,5-dimethoxyamphetamine (DOET) (4-ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)
4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-α-methylbenzeneethanamine)
4-chloro-2,5-dimethoxyamphetamine (4-chloro-2,5-dimethoxy-α-methyl-benzeneethanamine)
4-ethoxyamphetamine (4-ethoxy-α-methylbenzeneethanamine)
Benzphetamine (N-benzyl-N,α-dimethylbenzeneethanamine)
N-Propyl-3,4-methylenedioxy- amphetamine (α-methyl-N-propyl-1,3-benzodioxole-5-ethanamine)
N-(2-Hydroxyethyl)-α-meth-ylbenzeneethanamine
N-hydroxy-3,4-methylenedioxy- amphetamine (N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine)
3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-α-methylbenzeneethanamine)
Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any of its salts or derivatives
4-hydroxybutanoic acid (GHB) and any of its salts
Tapentadol (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-phenol), its salts, derivatives and isomers and salts of derivatives and isomers
AH-7921 (1-(3,4-dichlorobenzamidomethyl)cyclohexyldimethylamine), its salts, isomers and salts of isomers
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including:
Diphenidine (DEP) (1-(1,2-diphenylethyl)piperidine)
Methoxphenidine (2-MeO-Diphenidine, MXP) (1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine)
Ephenidine (NEDPA, EPE) (N-ethyl-1,2-diphenylethylamine)
Isophenidine (NPDPA) (N-isopropyl-1,2-diphenylethylamine)
but not including:
Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers
W-18 (-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]benzenesulfonamide), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
U-47700 (3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide), its salts, derivatives, isomers and analogues, and salts of derivatives, isomers and analogues, including:
Bromadoline (4-bromo-N-(2-(dimethylamino)cyclohexyl)benzamide)
U-47109 (3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)benzamide)
U-48520 (4-chloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide)
U-50211 (N-(2-(dimethylamino)cyclohexyl)-4-hydroxy-N-methylbenzamide)
U-77891 (3,4-dibromo-N-methyl-N-(1-methyl-1-azaspiro[4.5]decan-6-yl)benzamide)
Tramadol (2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol), its salts, isomers and salts of isomers and the following derivatives of tramadol and the salts, isomers and salts of isomers of those derivatives:
O-desmethyltramadol (3-[2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]-phenol)
N,O-didesmethyltramadol (3-[1-hydroxy-2-[(methylamino)methyl]cyclohexyl]-phenol)
Schedule II
Synthetic cannabinoid receptor type 1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomers — with the exception of any substance that is identical to any phytocannabinoid and with the exception of ((3S)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-3) and its salts — including those that fall within the following core chemical structure classes:
Any substance that has a 2-(cyclohexyl)phenol structure with substitution at the 1-position of the benzene ring by a hydroxy, ether or ester group and further substituted at the 5-position of the benzene ring, whether or not further substituted on the benzene ring to any extent, and substituted at the 3’-position of the cyclohexyl ring by an alkyl, carbonyl, hydroxyl, ether or ester, and whether or not further substituted on the cyclohexyl ring to any extent, including
Nabilone ((±)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one)
Parahexyl (3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol)
3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol (DMHP )
5-(1,1-dimethylheptyl)-2-(5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)phenol (CP 55,940 )
5-(1,1-dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol (CP 47,497 )
Any substance that has a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including
1-pentyl-3-(1-naphthoyl)indole (JWH-018 )
1-butyl-3-(1-naphthoyl)indole (JWH-073 )
1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122 )
1-hexyl-3-(1-naphthoyl)indole (JWH-019 )
1-(4-pentenyl)-3-(1-naphthoyl)indole (JWH-022)
1-butyl-3-(4-methoxy-1-naphthoyl)indole (JWH-080)
1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081 )
1-(2-morpholin-4-ylethyl)-3-(1-naphthoyl)indole (JWH-200 )
1-pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH-210 )
1-pentyl-3-(2-methoxy-1-naphthoyl)indole (JWH-267)
1-[(N-methylpiperidin-2-yl)methyl]-3-(1-naphthoyl)indole (AM-1220 )
1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM-2201 )
1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole (MAM-2201 )
1-(5-fluoropentyl)-3-(4-ethyl-1-naphthoyl)indole (EAM-2201 )
((3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-2 )
Any substance that has a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted on the pyrrole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including
1-pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole (JWH-307 )
Any substance that has a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including
1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250 )
1-pentyl-3-(2-methylphenylacetyl)indole (JWH-251 )
1-pentyl-3-(3-methoxyphenylacetyl)indole (JWH-302 )
Any substance that has a 3-benzoylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including
1-(1-methylpiperidin-2-ylmethyl)-3-(2-iodobenzoyl)indole (AM-2233 )
Any substance that has a 3-methanone(cyclopropyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the cyclopropyl ring to any extent, including
(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (UR-144 )
(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (5F-UR-144 )
(1-(2-(4-morpholinyl)ethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (A-796,260 )
Any substance that has a quinolin-8-yl 1H-indole-3-carboxylate structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the quinolin-8-yl ring to any extent, including
1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid (PB-22 )
1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid (5F-PB-22 )
Any substance that has a 3-carboxamideindazole structure with substitution at the nitrogen atom of the indazole ring, whether or not further substituted on the indazole ring to any extent and whether or not substituted at the carboxamide group to any extent, including
N-(adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide (AKB48)
N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-AKB48 )
N-(1-(aminocarbonyl)-2-methylpropyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA )
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA )
Any substance that has a 3-carboxamideindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted at the carboxamide group to any extent, including
N-(adamantan-1-yl)-1-fluoropentylindole-3-carboxamide (STS-135 )
N-(adamantan-1-yl)-1-pentylindole-3-carboxamide (APICA )
Schedule III
Methylphenidate (α-phenyl-2-piperidineacetic acid methyl ester) and any salts, derivatives, isomers, and analogues and salts of derivatives, isomers, and analogues, including:
Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)
Isopropylphenidate (isopropyl 2-phenyl-2-(piperidin-2-yl)acetate)
Propylphenidate (propyl 2-phenyl-2-(piperidin-2-yl)acetate)
3,4-Dichloromethylphenidate (methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate)
4-Methylmethylphenidate (methyl 2-(4-methylphenyl)-2-(piperidin-2-yl)acetate)
4-Fluoromethylphenidate (methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate)
Methylnaphthidate (methyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)
Ethylnaphthidate (ethyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)
Methaqualone (2-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone) and any salt thereof
Mecloqualone (2-methyl-3-(2-chlorophenyl)-4(3H)-quinazolinone) and any salt thereof 11
LSD (lysergic acid diethylamide) (N,N-diethyllysergamide) and any salt thereof
DET (N,N-Diethyltryptamine) (3-[(2-diethylamino) ethyl]indole) and any salt thereof
DMT (N,N-Dimethyltryptamine) (3-[(2-dimethylamino) ethyl]indole) and any salt thereof
JB-336 (N-Methyl-3-piperidyl benzilate or LBJ) (3-[(hydroxydiphenylacetyl)oxy]-1-methylpiperidine) and any salt thereof
Harmaline (4,9-dihydro-7-methoxy-1-methyl-3H-pyrido(3,4-b)indole) and any salt thereof
Harmalol (4,9-dihydro-1-methyl-3H-pyrido(3,4-b)indol-7-ol) and any salt thereof
Psilocin (3-[2-(dimethylamino)ethyl]-4-hydroxyindole) and any salt thereof
Psilocybin (3-[2-(dimethylamino)ethyl]-4-phosphoryloxyindole) and any salt thereof
PCE (N-(1-phenylcyclohexyl)ethylamine) and any salt thereof
TCP (1-[1-(2-Thienyl) cyclohexyl]piperidine) and any salt thereof
PCPr (1-Phenyl-N-propylcyclohexanamine) and any salt thereof
Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof
Mescaline (3,4,5-trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora)
4-Methylaminorex (4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) and any salt thereof
Cathinone ((-)-α-aminopropiophenone) and any salt thereof
Fenetylline (d,l-3,7-dihydro-1,3-dimethyl-7-(2-[(1-methyl-2-phenethyl)amino]ethyl)-1H-purine-2, 6-dione) and any salt thereof
Methcathinone (2-Methylamino-1-phenyl-1-propanone) and any salt thereof
Benzylcyclidine (1-[1-(Phenylmethyl)cyclohexyl]piperidine) and any salt thereof
4-Methyl-PCP (1-[1-(4-Methylphenyl)cyclohexyl]piperidine) and any salt thereof
[Repealed, SOR/2016-73, s. 1]
[Repealed, 2012, c. 1, s. 46]
[Repealed, 2012, c. 1, s. 46]
Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof
Etryptamine (3-(2-aminobutyl)indole) and any salt thereof
Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine) and any salt thereof
Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof
Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof
Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof
BZP (Benzylpiperazine ) (1-benzylpiperazine) and its salts, isomers and salts of isomers
TFMPP (Trifluoromethylphenylpiperazine ) (1-(3-trifluoromethylphenyl)piperazine) and its salts, isomers and salts of isomers
2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond to the following chemical description:
any substance that has a 1-amino-2-phenylethane structure substituted at the 2' and 5' or 2' and 6' positions of the benzene ring by an alkoxy or haloalkoxy group, or substituted at two adjacent carbon atoms of the benzene ring which results in the formation of a furan, dihydrofuran , pyran, dihydropyran or methylenedioxy group—whether or not further substituted on the benzene ring to any extent, whether or not substituted at the amino group by one or two, or a combination of, methyl , ethyl , propyl , isopropyl , hydroxyl , benzyl (or benzyl substituted to any extent) or benzylene (or benzylene substituted to any extent) groups and whether or not substituted at the 2-ethyl (beta carbon) position by a hydroxyl, oxo or alkoxy group—and its salts and derivatives and salts of derivatives, including:
4-bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe)
4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25C-NBOMe)
4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe)
4-bromo-2,5-dimethoxybenzeneethanamine (2C-B)
Schedule IV
Allobarbital (5,5-diallylbarbituric acid)
Alphenal (5-allyl-5-phenylbarbituric acid)
Amobarbital (5-ethyl-5-(3-methylbutyl)barbituric acid)
Aprobarbital (5-allyl-5-isopropylbarbituric acid)
Barbital (5,5-diethylbarbituric acid)
[Repealed, SOR/2017-13, s. 7]
Butabarbital (5-sec-butyl-5-ethylbarbituric acid)
Butalbital (5-allyl-5-isobutylbarbituric acid)
Butallylonal (5-(2-bromoallyl)-5-sec-butylbarbituric acid)
Butethal (5-butyl-5-ethylbarbituric acid)
Cyclobarbital (5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid)
Cyclopal (5-allyl-5-(2-cyclopenten-1-yl)barbituric acid)
Heptabarbital (5-(1-cyclohepten-1-yl)-5-ethylbarbituric acid)
Hexethal (5-ethyl-5-hexylbarbituric acid)
Hexobarbital (5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid)
Mephobarbital (5-ethyl-1-methyl-5-phenylbarbituric acid)
Methabarbital (5,5-diethyl-1-methylbarbituric acid)
Methylphenobarbital (5-ethyl-1-methyl-5-phenylbarbituric acid)
Propallylonal (5-(2-bromoallyl)-5-isopropylbarbituric acid)
Pentobarbital (5-ethyl-5-(1-methylbutyl)barbituric acid)
Phenobarbital (5-ethyl-5-phenylbarbituric acid)
Probarbital (5-ethyl-5-isopropylbarbituric acid)
Phenylmethylbarbituric acid (5-methyl-5-phenylbarbituric acid)
Secobarbital (5-allyl-5-(1-methylbutyl)barbituric acid)
Sigmodal (5-(2-bromoallyl)-5-(1-methylbutyl) barbituric acid)
Talbutal (5-allyl-5-sec-butylbarbituric acid)
Vinbarbital (5-ethyl-5-(1-methyl-1-butenyl)barbituric acid)
Vinylbital (5-(1-methylbutyl)-5-vinylbarbituric acid)
but not including:
Barbituric acid (2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts
1,3-dimethylbarbituric acid (1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts
Thiobarbiturates, their salts and derivatives including:
Thialbarbital (5-allyl-5-(2-cyclohexen-1-yl)-2-thiobarbituric acid)
Thiamylal (5-allyl-5-(1-methylbutyl)-2-thiobarbituric acid)
Thiobarbituric acid (2-thiobarbituric acid)
Thiopental (5-ethyl-5-(1-methylbutyl)-2-thiobarbituric acid)
Chlorphentermine (1-(p-chlorophenyl)-2-methyl-2-aminopropane) and any salt thereof
Diethylpropion (2-(diethylamino)propiophenone) and any salt thereof
Phendimetrazine (d-3,4-dimethyl-2-phenylmorpholine) and any salt thereof
Phenmetrazine (3-methyl-2-phenylmorpholine) and any salt thereof
Pipradrol (α,α-diphenyl-2-piperidinemethanol) and any salt thereof
Phentermine (α,α-dimethylbenzeneethanamine) and any salt thereof
Butorphanol (l-N-cyclobutylmethyl-3,14-dihydroxymorphinan) and any salt thereof
Nalbuphine (N-cyclobutylmethyl-4,5-epoxy-morphinan-3,6,14-triol) and any salt thereof
Glutethimide (2-ethyl-2-phenylglutarimide)
Clotiazepam (5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno[2,3-e]-1,4-diazepin-2-one) and any salt thereof
Ethchlorvynol (ethyl-2-chlorovinyl ethynyl carbinol)
Ethinamate (1-ethynylcyclohexanol carbamate)
Mazindol (5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol)
Meprobamate (2-methyl-2-propyl-1,3-propanediol dicarbamate)
Methyprylon (3,3-diethyl-5-methyl-2,4-piperidinedione)
Benzodiazepines , their salts and derivatives, including:
Alprazolam (8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4] benzodiazepine)
Bromazepam (7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1, 4-benzodiazepin-2-one)
Brotizolam (2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine)
Camazepam (7-chloro-1,3-dihydro-3-(N,N- dimethylcarbamoyl)-1-methyl-5-phenyl-2H-1, 4-benzodiazepin-2-one)
Chlordiazepoxide (7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4-oxide)
Clobazam (7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione)
Clonazepam (5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one)
Clorazepate (7-chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid)
Cloxazolam (10-chloro-11b-(o-chlorophenyl)-2,3, 7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin 6-(5H)-one)
Delorazepam (7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
Diazepam (7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one)
Estazolam (8-chloro-6-phenyl-4H-s-triazolo [4,3-a][1,4]benzodiazepine)
Ethyl Loflazepate (ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-carboxylate)
Fludiazepam (7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one)
[Repealed, SOR/98-173, s. 2]
Flurazepam (7-chloro-1-[2-(diethylamino) ethyl]-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
Halazepam (7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepin-2-one)
Haloxazolam (10-bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one)
Ketazolam (11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-[1,3]-oxazino-[3,2-d][1,4] benzodiazepine-4,7(6H)-dione)
Loprazolam (6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-one)
Lorazepam (7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one)
Lormetazepam (7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one)
Medazepam (7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine)
Midazolam (8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine)
Nimetazepam (1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one)
Nitrazepam (1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one)
Nordazepam (7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one)
Oxazepam (7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one)
Oxazolam (10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d] [1,4]benzodiazepin-6(5H)-one)
Pinazepam (7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-benzodiazepin-2-one)
Prazepam (7-chloro-1-(cyclopropylmethyl)-1, 3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one)
Quazepam (7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione)
Temazepam (7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one)
Tetrazepam (7-chloro-5-(cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one)
Triazolam (8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine)
but not including:
Clozapine (8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine) and any salt thereof
Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any salts or derivatives thereof
Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) and its salts
Clozapine N-oxide (8-chloro-11-(4-methyl-4-oxido-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine) and its salts
Cathine (d-threo-2-amino-1-hydroxy-1-phenylpropane)
Fencamfamin (d,l-N-ethyl-3-phenylbicyclo[2,2,1] heptan-2-amine) and any salt thereof
Fenproporex (d,l-3-[(α-methylphenethyl)amino]propionitrile) and any salt thereof
Mefenorex (d,l-N-(3-chloropropyl)-α-methylbenzeneethanamine) and any salt thereof
Anabolic steroids and their derivatives including:
Androisoxazole (17ß-hydroxy-17α-methylandrostano [3,2-c]isoxazole)
Androstanolone (17ß-hydroxy-5α-androstan-3-one)
Androstenediol (androst-5-ene-3ß,17ß-diol)
Bolandiol (estr-4-ene-3ß,17ß-diol)
Bolasterone (17ß-hydroxy-7α,17-dimethylandrost-4-en-3-one)
Bolazine (17ß-hydroxy-2α-methyl-5α-androstan-3-one azine)
Boldenone (17ß-hydroxyandrosta-1,4-dien-3-one)
Bolenol (19-nor-17α-pregn-5-en-17-ol)
Calusterone (17ß-hydroxy-7ß,17-dimethylandrost-4-en-3-one)
Clostebol (4-chloro-17ß-hydroxyandrost-4-en-3-one)
Drostanolone (17ß-hydroxy-2α-methyl-5α-androstan-3-one)
Enestebol (4, 17ß-dihydroxy-17-methylandrosta-1,4-dien-3-one)
Epitiostanol (2α, 3α-epithio-5α-androstan-17ß-ol)
Ethylestrenol (19-nor-17α-pregn-4-en-17-ol)
4-Hydroxy-19-nor testosterone (4-HO-Nandrolone)
Fluoxymesterone (9-fluoro-11ß,17ß-dihydroxy-17-methylandrost-4-en-3-one)
Formebolone (11α, 17ß-dihydroxy-17-methyl-3-oxoandrosta-1,4 di-en-2-carboxaldehyde)
Furazabol (17-methyl-5α-androstano[2,3-c] furazan-17ß-ol)
Mebolazine (17ß-hydroxy-2α,17-dimethyl-5α-androstan-3-one azine)
Mesabolone (17ß-[(1-methoxycyclohexyl)oxy]-5α-androst-1-en-3-one)
Mesterolone (17ß-hydroxy-1α-methyl-5α-androstan-3-one)
Metandienone (17ß-hydroxy-17-methylandrosta-1,4-dien-3-one)
Metenolone (17ß-hydroxy-1-methyl-5α-androst-1-en-3-one)
Methandriol (17α-methylandrost-5-ene-3ß,17ß-diol)
Methyltestosterone (17ß-hydroxy-17-methylandrost-4-en-3-one)
Metribolone (17ß-hydroxy-17-methylestra-4, 9,11-trien-3-one)
Mibolerone (17ß-hydroxy-7α,17-dimethylestr-4-en-3-one)
Nandrolone (17ß-hydroxyestr-4-en-3-one)
Norboletone (13-ethyl-17ß-hydroxy-18, 19-dinorpregn-4-en-3-one)
Norclostebol (4-chloro-17ß-hydroxyestr-4-en-3-one)
Norethandrolone (17α-ethyl-17ß-hydroxyestr-4-en-3-one)
Oxabolone (4,17ß-dihydroxyestr-4-en-3-one)
Oxandrolone (17ß-hydroxy-17-methyl-2-oxa-5α-androstan-3-one)
Oxymesterone (4,17ß-dihydroxy-17-methylandrost-4-en-3-one)
Oxymetholone (17ß-hydroxy-2-(hydroxymethylene)-17-methyl-5α-androstan-3-one)
Prasterone (3ß-hydroxyandrost-5-en-17-one)
Quinbolone (17ß-(1-cyclopenten-1-yloxy) androsta-1,4-dien-3-one)
Stanozolol (17ß-hydroxy-17-methyl-5α-androstano [3,2-c]pyrazole)
Stenbolone (17ß-hydroxy-2-methyl-5α-androst-1-en-3-one)
Testosterone (17ß-hydroxyandrost-4-en-3-one)
Tibolone ((7α,17α)-17-hydroxy-7-methyl-19-norpregn-5(10) en-20-yn-3-one)
Tiomesterone (1α,7α-bis(acetylthio)-17ß -hydroxy-17-methylandrost-4-en-3-one)
Trenbolone (17ß-hydroxyestra-4,9,11-trien-3-one)
Zeranol (3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1-one)
Zolpidem (N,N,6-trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide) and any salt thereof
Pemoline (2-amino-5-phenyl-oxazolin-4-one) and any salt thereof
Pyrovalerone (4′-methyl-2-(1-pyrrolidinyl)valerophenone) and any salt thereof
Salvia divinorum (S. divinorum), its preparations and derivatives, including:
Salvinorin A ((2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester)
Schedule V
(Sections 2, 5 to 7.1, 10, 55 and 60.1)
1996, c. 19, Sch. V; SOR/2002-361, s. 1; SOR/2003-32, s. 7; 2017, c. 7, s. 50.
Schedule VI (Precursors)
PART 1
Class A Precursors [ notes 1]
Acetic anhydride
N-Acetylanthranilic acid (2-acetamidobenzoic acid) and its salts
Anthranilic acid (2-aminobenzoic acid) and its salts
Ephedrine (erythro-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing ephedrine or any of its salts
Ergometrine (9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide) and its salts
Ergotamine (12′-hydroxy-2′-methyl-5′-(phenylmethyl)ergotaman-3′,6′,18-trione) and its salts
Isosafrole (5-(1-propenyl)-1,3-benzodioxole)
Lysergic acid (9,10-didehydro-6-methylergoline-8-carboxylic acid) and its salts
3,4-Methylenedioxyphenyl-2-propanone (1-(1,3-benzodioxole)-2-propanone), its derivatives and analogues and salts of derivatives and analogues, including:
methyl 3-(1,3 benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (MMDMG)
Norephedrine (Phenylpropanolamine) and its salts
1-Phenyl-2-propanone, its derivatives and analogues and salts of derivatives and analogues, including:
methyl 2-methyl-3-phenyloxirane-2-carboxylate (BMK methyl glycidate)
3-oxo-2-phenylbutanamide (α- phenylacetoacetamide-APAA)
Phenylacetic acid and its salts
Piperidine and its salts
Piperonal (1,3-benzodioxole-5-carboxaldehyde)
Potassium permanganate
Pseudoephedrine (threo-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing pseudoephedrine or any of its salts
Safrole (5-(2-propenyl)-1,3-benzodioxole) and any essential oil containing more than 4% safrole
Gamma-butyrolactone (dihydro-2(3H)-furanone)
1,4-butanediol
Red Phosphorus
White Phosphorus
Hypophosphorous acid , its salts and derivatives
Hydriodic acid
Alpha-phenylacetoacetonitrile and its salts, isomers and salts of isomers
Propionyl chloride
1-Phenethyl-4-piperidone and its salts
4-Piperidone and its salts
Norfentanyl (N-phenyl-N-piperidin-4-ylpropanamide), its salts, derivatives and analogues and salts of derivatives and analogues
1-Phenethylpiperidin-4-ylidenephenylamine and its salts
N -Phenyl-4-piperidinamine (N -phenylpiperidin-4-amine), its salts, derivatives and analogues and salts of derivatives and analogues, including:
4-anilino-1-boc-piperidine (tert -butyl 4-(phenylamino)piperidine-1-carboxylate)
4-fluoro anilino-1-boc-piperidine (tert -butyl 4-((4-fluorophenyl)amino)piperidine-1-carboxylate)
N -(4-fluorophenyl)-4-piperidinamine (N -(4-fluorophenyl)piperidin-4-amine)
4-bromo anilino-1-boc-piperidine (tert -butyl 4-((4-bromophenyl)amino)piperidine-1-carboxylate)
N1 ,N1 ,N2 -trimethylcyclohexane-1,2-diamine and its salts
Benzylfentanyl (N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide), its salts, derivatives and analogues and salts of derivatives and analogues
PART 2
Class B Precursors [ notes 2]
PART 3
Preparations and Mixtures
Any preparation or mixture that contains a precursor set out in Part 1, except items 20 to 23 [Red Phosphorus; White Phosphorus; Hypophosphorous acid, its salts and derivatives; Hydriodic acid], or in Part 2.
Schedule VII
[Repealed, 2018, c. 16, s. 205]
Schedule VIII
[Repealed, 2018, c. 16, s. 205]
Schedule IX
Manual, semi-automatic or fully automatic device that may be used to compact or mould powdered, granular or semi-solid material to produce coherent solid tablets
Manual, semi-automatic or fully automatic device that may be used to fill capsules with any powdered, granular, semi-solid or liquid material
Laws – Penalties
Possession
If tried as an indictable offence , the defendant is liable to:
Schedule I: Maximum 3 years' imprisonment
Schedule II: Maximum 2 years' imprisonment
Schedule III: Maximum 1 years' imprisonment
Schedule IV: It is not an indictable offence to possess a Schedule IV substance for personal use.
If tried as a summary conviction offence , the defendant is liable to:
Schedule I, II, or III: Maximum $1000 fine for the first offence and/or a maximum 6-month term of imprisonment, increasing to a maximum fine of $2000 for each subsequent offense and/or a maximum of 1 year in prison.
Schedule IV: It is not a summary offence to possess a Schedule IV substance for personal use.
Section (4), Subsection (2) of the CDSA reads that any person who obtains or who makes any attempt to obtain a Schedule I through IV substance from a physician without fully disclosing the details of any previous instances of obtaining a Schedule I through IV substance in the preceding thirty (30) days, a practice often referred to as "doctor shopping ",[ 3] is guilty of a summary or indictable offense, as per Section (4), Subsection (7)(a) and (b).[ 4]
These drugs are considered lawful (and thus without penalty) if the person from whom the substance, precursor or property was seized came into possession of it lawfully and continued to deal with it lawfully, such as through a prescription by a prescribing practitioner.[ 5]
Trafficking/Possession for the Purpose of
If tried as an indictable offence , the defendant is liable to:
Schedule I or Schedule II : Maximum 4 years' imprisonment
Schedule III: Maximum 4 years' imprisonment
Schedule IV: Maximum 2 years' imprisonment
Or, if tried as a summary conviction , the defendant is liable to:
Schedule III: Maximum 9 months' imprisonment
Schedule IV: Maximum 6 months' imprisonment
Smuggling/Possession for the Purpose of Distribution
If tried as an indictable offence , the defendant is liable to:
Schedule I or Schedule II : Maximum 4 years' imprisonment
Mandatory minimum 1 year's imprisonment for exporting a Schedule I drug under 1 kg (2 lb), 2 years if amount exceeds 1 kg (2 lb)
Schedule III or Schedule IV : Maximum 4 years' imprisonment
Schedule V or Schedule VI : Maximum 2 years' imprisonment
Or, if tried as a summary conviction , the defendant is liable to:
Schedule III or Schedule IV : Maximum 9 months' imprisonment
Schedule V or Schedule VI : Maximum 6 months' imprisonment
Production
If tried as an indictable offence , the defendant is liable to:
Schedule I or Schedule II : Maximum 4 years imprisonment
minimum 2 years' imprisonment
Schedule III: Maximum 4 years' imprisonment
Schedule IV: Maximum 2 years' imprisonment
Or, if tried as a summary conviction , the defendant is liable to:
Schedule III: Maximum 9 months' imprisonment
Schedule IV: Maximum 6 months' imprisonment
See also
Notes
^ Each Class A precursor includes synthetic and natural forms.
^ Each Class B precursor includes synthetic forms.
References
External links